Share ownership Incyte Corporation

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 17/03/2026 am IST			5-day change	1st Jan Change
93.00 ^USD	+0.50%		-3.06%	-5.84%

11/03	Incyte Corporation Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 08:30 AM
10/03	Incyte Corporation Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 09:20 AM

Share class: Incyte Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	19,35,24,350	18,87,04,927 ( 97.51 %)	0	97.51 %

Major shareholders: Incyte Corporation

Name	Equities	%	Valuation
Baker Bros. Advisors LP 15.63 %	3,11,04,486	15.63 %	3 150 M $
Baker Bros. Advisors LP 15.45 %	3,07,43,991	15.45 %	3 113 M $
Vanguard Fiduciary Trust Co. 10.01 %	1,99,11,434	10.01 %	2 016 M $
BlackRock Advisors LLC 7.039 %	1,40,07,975	7.039 %	1 419 M $
Dodge & Cox 6.664 %	1,32,61,742	6.664 %	1 343 M $
STATE STREET CORPORATION 4.852 %	96,56,403	4.852 %	978 M $
AQR Capital Management LLC 3.377 %	67,20,024	3.377 %	681 M $
Geode Capital Management LLC 2.509 %	49,93,012	2.509 %	506 M $
Renaissance Technologies LLC 1.999 %	39,78,332	1.999 %	403 M $
LSV Asset Management 1.977 %	39,33,758	1.977 %	398 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	104.79%
Other	7.48%
State Street Corp.	4.85%
Individuals	0.95%
Skandinaviska Enskilda Banken AB	0.38%
SEI Investments Co.	0.35%
Schweizerische Nationalbank	0.23%
Sumitomo Mitsui Trust Group, Inc.	0.22%
Swedbank AB	0.18%
Governments	0.13%
Manulife Financial Corp.	0.08%
The Bank of Nova Scotia	0.06%
Danske Bank A/S	0.05%
Münchener Rückversicherungs-Gesellschaft AG	0.03%
Northwest Bancshares, Inc. (Pennsylvania)	0.03%
Banco Bilbao Vizcaya Argentaria SA	0.02%
The Allstate Corp.	0.01%
Fifth Third Bancorp	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	99.45%
United Kingdom	6.81%
Canada	1.92%
Australia	1.79%
Netherlands	1.37%
France	1.24%
Sweden	1.16%
Switzerland	1.12%
Norway	0.97%
Individuals	0.95%
Japan	0.62%
Luxembourg	0.59%
Denmark	0.47%
Ireland	0.32%
Germany	0.27%
Belgium	0.15%
Italy	0.12%
South Korea	0.11%
Puerto Rico	0.07%
New Zealand	0.06%
Spain	0.06%
South Africa	0.04%
China	0.04%
Hong Kong	0.03%
Finland	0.03%
Czech Republic	0.02%
Austria	0.02%
Liechtenstein	0.01%
Brazil	0.01%
Mexico	0.01%
Taiwan	0.01%
Estonia	0.01%

Based on 1000 largest holdings

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).

Employees

2,844

Sector

Pharmaceuticals

More about the company